Search results
Results from the WOW.Com Content Network
Alendronic acid, sold under the brand name Fosamax among others, is a bisphosphonate medication used to treat osteoporosis and Paget's disease of bone. [4] It is taken by mouth. [4]
Bisphosphonates have been used to reduce fracture rates in children with the disease osteogenesis imperfecta [24] and to treat otosclerosis [25] by minimizing bone loss. Other bisphosphonates, including medronate (R 1 =H, R 2 =H) and oxidronate (R 1 =H, R 2 =OH), are mixed with radioactive technetium and injected, as a way to image bone and ...
The U.S. Food and Drug Administration (FDA) recently approved adding to Wegovy's label that the drug can also reduce the risk of heart events by 20% in people with obesity , for example.
Ibandronic acid is a bisphosphonate medication used in the prevention and treatment of osteoporosis and metastasis-associated skeletal fractures in people with cancer. [4] It may also be used to treat hypercalcemia (elevated blood calcium levels). It is typically formulated as its sodium salt ibandronate sodium. [medical citation needed]
How to Start Losing Weight: 6 Tips. Many things about weight loss might be out of your control — like genetics or your set-point weight. But the good news is there are many things you can ...
Bone loss increases after menopause in women due to lower levels of estrogen, and after andropause in older men due to lower levels of testosterone. [10] Osteoporosis may also occur due to a number of diseases or treatments, including alcoholism , anorexia , hyperthyroidism , kidney disease , and after oophorectomy (surgical removal of the ...
Your healthcare provider may prescribe you a 0.25-milligram (mg) dose to start. This may increase to 0.5 milligrams after four weeks, 1 milligrams after another four weeks, and 2 milligrams after ...
Alendronic acid/colecalciferol, sold under the brand name Fosamax Plus D among others, is a medication for the treatment of osteoporosis in men or in postmenopausal women. [3] [2] [4] [6] Alendronic acid/colecalciferol was approved for use in the United States and in the European Union in 2005. [7] [5]